Global Drug Pipeline
Furiex has a robust and diversified drug pipeline that includes two marketed products and three programs in development across multiple therapeutic areas.
Our drug pipeline demonstrates proven success and our depth of knowledge enables us to select what we believe are promising therapeutic candidates and apply innovative science to advance candidates through development rapidly.
Unlike traditional biotechnology companies whose business models are based on either a technology platform or a specific therapeutic area, Furiex has a diversified approach and is focused on progressing drug candidates through clinical testing and regulatory approval. Consequently, our pipeline is comprised of products in multiple therapeutic indications spanning clinical development through to commercialization.
